Literature DB >> 11793394

Experimental infection of Macaca nemestrina with a Toronto Norwalk-like virus of epidemic viral gastroenteritis.

D S Subekti1, P Tjaniadi, M Lesmana, J McArdle, D Iskandriati, I N Budiarsa, P Walujo, I H Suparto, I Winoto, J R Campbell, K R Porter, D Sajuthi, A A Ansari, B A Oyofo.   

Abstract

Norwalk virus (NV) and Norwalk-like viruses (NLVs) are common etiologic agents of viral gastroenteritis. Viral gastroenteritis is a common disease that is highly transmissible, spreading rapidly through families, institutions, and communities. Because methods for in vitro cultivation of Norwalk etiologic agents are not available, information regarding this syndrome has come largely from studies in human volunteers. Sequential passaging of an NLV through an immunoincompetent newborn pigtail macaque (Macaca nemestrina) may allow for the adaptation of a human NLV to a primate host, thus providing an animal model for investigating this disease. A fecal filtrate of human origin containing NLV, Toronto virus P2-A, was obtained from a patient during an epidemic of viral gastroenteritis. The filtrate was administered via nasogastric tube to three newborn pigtailed macaques. Clinical illness, which was characterized by diarrhea, dehydration, and vomiting, occurred in three monkeys. Reverse transcription-polymerase chain reaction (RT-PCR) and oligonucleotide probe analysis of RNA extracted from the stool samples following infection revealed viral RNA in all inoculated monkeys. Infection was also transmitted experimentally by feeding two additional newborn macaques a fecal filtrate prepared from the three previously infected animals. Detection of viral RNA in the stools of animals that received the fecal filtrate indicates that viral replication occurred in association with clinical illness. The susceptibility of Macaca nemestrina to infection with a Norwalk-like agent will facilitate the study of the mechanisms of the pathogenesis of NLV. This system may also have the potential to serve as a vaccine test model for human epidemic viral gastroenteritis. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11793394     DOI: 10.1002/jmv.2159

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  22 in total

1.  Genogroup II noroviruses efficiently bind to heparan sulfate proteoglycan associated with the cellular membrane.

Authors:  Masaru Tamura; Katsuro Natori; Masahiko Kobayashi; Tatsuo Miyamura; Naokazu Takeda
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

2.  Detection of norovirus-, sapovirus- and rhesus enteric calicivirus-specific antibodies in captive juvenile macaques.

Authors:  Tibor Farkas; Jason Dufour; Xi Jiang; Karol Sestak
Journal:  J Gen Virol       Date:  2009-11-04       Impact factor: 3.891

3.  Binding of Norwalk virus-like particles to ABH histo-blood group antigens is blocked by antisera from infected human volunteers or experimentally vaccinated mice.

Authors:  Patrick R Harrington; Lisa Lindesmith; Boyd Yount; Christine L Moe; Ralph S Baric
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

4.  Median infectious dose of human norovirus GII.4 in gnotobiotic pigs is decreased by simvastatin treatment and increased by age.

Authors:  Tammy Bui; Jacob Kocher; Yanru Li; Ke Wen; Guohua Li; Fangning Liu; Xingdong Yang; Tanya LeRoith; Ming Tan; Ming Xia; Weiming Zhong; Xi Jiang; Lijuan Yuan
Journal:  J Gen Virol       Date:  2013-06-26       Impact factor: 3.891

Review 5.  Vaccine against norovirus.

Authors:  Ming Tan; Xi Jiang
Journal:  Hum Vaccin Immunother       Date:  2014-05-05       Impact factor: 3.452

6.  Pathogenesis of a genogroup II human norovirus in gnotobiotic pigs.

Authors:  Sonia Cheetham; Menira Souza; Tea Meulia; Sheila Grimes; Myung Guk Han; Linda J Saif
Journal:  J Virol       Date:  2006-11       Impact factor: 5.103

7.  Chimpanzees as an animal model for human norovirus infection and vaccine development.

Authors:  Karin Bok; Gabriel I Parra; Tanaji Mitra; Eugenio Abente; Charlene K Shaver; Denali Boon; Ronald Engle; Claro Yu; Albert Z Kapikian; Stanislav V Sosnovtsev; Robert H Purcell; Kim Y Green
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-20       Impact factor: 11.205

8.  Characterization of a rhesus monkey calicivirus representing a new genus of Caliciviridae.

Authors:  Tibor Farkas; Karol Sestak; Chao Wei; Xi Jiang
Journal:  J Virol       Date:  2008-04-02       Impact factor: 5.103

9.  Trans activity of the norovirus Camberwell proteinase and cleavage of the N-terminal protein encoded by ORF1.

Authors:  Ee Ling Seah; John A Marshall; Peter J Wright
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

10.  Cytokine and antibody responses in gnotobiotic pigs after infection with human norovirus genogroup II.4 (HS66 strain).

Authors:  M Souza; S M Cheetham; M S P Azevedo; V Costantini; L J Saif
Journal:  J Virol       Date:  2007-06-20       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.